FDA: Alzheimer's, Amyvid (florbetapir)
From MedPage Today:
FDA Puts Early Alzheimer's Test on Hold
By Peggy Peck, Executive Editor
MedPage Today
Published: March 18, 2011
[snip]
"The FDA will not approve the novel contrast agent, florbetapir -- widely touted as a breakthrough for early diagnosis of Alzheimer's disease -- until manufacturer Eli Lilly puts a training program in place, the company announced."
[snip]
Read the article.
FDA Puts Early Alzheimer's Test on Hold
By Peggy Peck, Executive Editor
MedPage Today
Published: March 18, 2011
[snip]
"The FDA will not approve the novel contrast agent, florbetapir -- widely touted as a breakthrough for early diagnosis of Alzheimer's disease -- until manufacturer Eli Lilly puts a training program in place, the company announced."
[snip]
Read the article.
posted by Anthony Risser at 8:22 AM
1 Comments:
Anthony,
I am an editor at The Nerve, BU's neuroscience magazine and blog. Since we're just starting up, we are looking to create a following of readers interested in the mind and brain. Could you please add a link to our site on your blog? We'd be glad to do the same for you.
Best,
The Nerve Editors
http://blogs.bu.edu/ombs/
Post a Comment
<< Home